See also this year's filing and all EDGAR filings for this company.
PDF Report 0001607678_2020_Viking_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001607678, Viking Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 283,501,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 755,000 |
| 4 | LiabilitiesCurrent | 6,777,000 |
| 5 | LiabilitiesNoncurrent | 360,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,401,674 |
| 9 | ResearchAndDevelopmentExpense | 32,506,911 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 6,067,069 |
| 13 | remainder_ComprehensiveNetIncome | -402,189 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 284,256,000 |
| 1 | Liabilities | 7,137,000 |
| 2 | Expenses | 41,908,585 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 277,119,000 |
| 5 | NetIncome | -35,841,516 |
| 6 | ComprehensiveNetIncome | -36,042,610 |
| 7 | BaseVar | 169,885,422 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.90 |
| 9 | EconomicCapitalRatio | 4.32 |